Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision

Expert Review of Neurotherapeutics
Roberto Bergamaschi

Abstract

With the development of new immunomodulating therapies, with which early use is strongly encouraged, it is crucial to be in possession of reliable clinical predictors of multiple sclerosis evolution. Prognostic factors are important to patients wanting to be informed about their prospects; to the clinician needing to individualize patients requiring immune treatments at an early stage of the disease; and also to the researcher needing to to improve the design and analysis of the clinical therapeutic trials and observational studies. Frequentist analyses have indicated a poor prognosis for male gender, late age at onset, motor, cerebellar and sphincter involvement at onset, progressive course at onset, short inter-attack interval, high number of early attacks; and a relevant early residual disability. A recent application of a Bayesian analysis led to the construction of more detailed models of the natural history of multiple sclerosis and the estimated risk of unfavorable evolution at an individual patient level.

References

Feb 1, 1988·Journal of the Neurological Sciences·A L Hume, S G Waxman
Nov 1, 1984·Acta Neurologica Scandinavica·B R VisscherJ P Dudley
Dec 1, 1983·Neurology·J NoseworthyG Ebers
Jun 1, 1982·Archives of Neurology·R DetelsJ P Dudley
Sep 1, 1982·Acta Neurologica Scandinavica·S PoserW Poser
Feb 1, 1995·Archives of Ophthalmology·R W Beck
Mar 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·M TrojanoP Livrea
Jan 1, 1994·Annals of Neurology·B G Weinshenker
Feb 1, 1993·Brain : a Journal of Neurology·B Runmarker, O Andersen
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M PaneliusJ Ruutiainen
Apr 1, 1996·Archives of Neurology·B G WeinshenkerJ Baskerville
Apr 29, 1998·Brain : a Journal of Neurology·J I O'RiordanD H Miller
Jul 31, 1998·The New England Journal of Medicine·C ConfavreuxT Moreau
Jul 17, 1999·Multiple Sclerosis : Clinical and Laboratory Research·Z M LevićJ Drulović
Aug 24, 1999·BMJ : British Medical Journal·D J SpiegelhalterK R Abrams
Nov 7, 2000·Journal of Neuroimmunology·P D Drew, J A Chavis
Nov 18, 2000·The New England Journal of Medicine·C ConfavreuxP Adeleine
Feb 24, 2001·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·R BergamaschiV Cosi
May 30, 2001·Lancet·G ComiUNKNOWN Early Treatment of Multiple Sclerosis Study Group
Sep 6, 2001·Journal of the Neurological Sciences·R BergamaschiV Cosi
Oct 24, 2001·Brain : a Journal of Neurology·P FuhrL Kappos
Nov 29, 2001·Multiple Sclerosis : Clinical and Laboratory Research·G RamsaransingJ De Keyser
Dec 26, 2001·Archives of Neurology·J R AvasaralaJ L Trotter
Dec 18, 2001·Brain Research. Brain Research Reviews·G P Cardona-GómezL M Garcia-Segura
Jan 18, 2002·The New England Journal of Medicine·Peter A BrexDavid H Miller
Jan 24, 2002·Neurology·D S GoodinUNKNOWN Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Pra
Mar 29, 2002·Annals of Neurology·Maria TrojanoPaolo Livrea
Jul 12, 2002·Journal of Neurology·A Carlos SantosDouglas L Arnold

❮ Previous
Next ❯

Citations

Oct 9, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Paolo A Muraro, Bibiana Bielekova
May 10, 2007·BMC Medical Informatics and Decision Making·M DaumerUNKNOWN Sylvia Lawry Centre for Multiple Sclerosis Research
Sep 24, 2010·Genes and Immunity·C C WallineJ J Bright
Mar 21, 2012·Acta Neurologica Scandinavica·D HorakovaE Havrdova
Mar 10, 2012·Clinical Neurology and Neurosurgery·T KalincikE Havrdova
Jan 23, 2008·Multiple Sclerosis : Clinical and Laboratory Research·M A LeoneF Monaco
Jun 2, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Roberto BergamaschiMaria Trojano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.